Jay Udani, MD, and Mary Hardy, MD, from Medicus Research in Northridge, CA, led the pilot study, entitled, “The effect of HMRlignan on mammalian lignan and estrogen metabolite levels in post-menopausal women: A randomized, double-blind, single dummy, parallel group, pilot study.” Researchers analyzed changes in enterolactone levels and estrogen metabolites following ingestion of the plant lignan hydroxymatairesinol (HMRlignan) and found significant improvement in reported hot flashes by the study participants.
In addition to winning the first place award, the HMRlignan research will be published in an upcoming edition of the Journal for Alternative and Complementary Medicine.
The Linnea-manufactured HMRlignan—the lignan product utilized in the study—is a naturally occurring plant lignan from the Norway spruce (Picea abies). Clinical research has shown HMRlignan to be a highly efficient enterolactone precursor. In addition to raising enterolactone levels, HMRlignan has also been shown to provide significant blood plasma levels of the strong antioxidant and free radical scavenger HMR.
For further information: 888-253-0044.